Leadership

 Dr. Tepper has over 30 years of experience in the biotechnology and pharmaceutical industry. He has led drug discovery & drug development programs that span a wide range of therapeutic areas including Oncology, Immunology, Rheumatology, Endocrinology, Metabolic Diseases, CNS, Inflammation and Pain. Following a 15-year career in large Pharma R&D, in 2002 Dr Tepper left large Pharma to become an entrepreneur whereby he founded multiple successful biotech companies. In leading these companies, he served on the executive management team in C-level positions where he conceived of and led the execution of the business & commercialization plan. In the last 15 years, Dr. Tepper has raised over $200M in capital for his ventures. He has taken two of his companies’ public (Corbus Pharmaceuticals and RXi Pharmaceuticals) and sold another company (Primatope sold to Kiniksa) in a trade sale. 

 Dr. Tepper earned a Ph.D. in Biochemistry & Biophysics from Columbia University, College of Physicians and Surgeons, New York, and a B.A in Chemistry with Highest Honors from Clark University, Worcester, Mass. He did his postdoctoral fellowship at University of Massachusetts Medical School, Worcester in the laboratory of Michael P. Czech. He has over 50 scientific publications and is the co-inventor of multiple drug related patents. 

Dr. Veves is a pioneer of the biotechnology industry. He is an outstanding biomedical entrepreneur with an international reputation in cytokines, therapeutic antibodies, and pharmaceutical drug development. During his 25-year career, he has written or coauthored eight books, over 250 papers/chapters, over 30 patents, and he has served on the editorial boards of six journals. His work on therapeutic antibodies and other protein therapeutics has spanned the entire range of biopharmaceutical product development from target discovery, process science to advanced clinical trials. 

BIO

BIO